NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/01/2024
Voltar para busca
Dado oficial do USPTO
G
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
60
Atualização mais recente
09/01/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 41, 42, 44
Data de depósito
08/02/2019
Data de registro
09/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/01/2024
Última transação
09/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
03
Localização do titular
Toronto, CA
Examinador
SABAGH, LAILA
Unidade examinadora
N90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a stylized, rounded lower case "G" having a tilted teardrop-shaped upper portion and floating, curved lower portion.
Titulares e representantes
Titulares
Inagene Diagnostics Inc.
Representantes
MATTHEW WARNER-BLANKENSHIP Dentons Davis Brown
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Advertising the goods and services of others focused on the application of personal genetic information for pain managementmental health and other comorbid conditions; developing promotional campaigns focused on the application of personal genetic information for pain managementmental health and other comorbid conditionsmarketing servicesmarketing consultancy for businesses in the field of personal genetic information for pain managementmental health and other comorbid conditionsall the foregoing not including veterinary or plant applications
Classe 41
Providing online non-downloadable audio and video recordings containing information in the field of medical testing servicesgenetic testing and genetic screening over a global computer network
Classe 42
Genetic testing and genetic screening services for scientific research purposes; scientific research in the fields of genomics and genetics; scientific research in the application of personal genetic information with respect to medical or nutritional treatmentspharmaceuticals and clinical trials; providing genetic-based nutritional and pharmaceutical research information via the internet and via printed publications; providing clinical laboratory testing servicespharmacogenetic testsgene sequencing-based tests and genotyping based on the assessmentdevelopment and application of human genomic discoveries in the pharmaceuticalinformatics and human clinical diagnostic industriesall the foregoing not including veterinary or plant applications; medical research in the fields of genomics and genetics; providing genetic-based medical research information via the internet and via printed publications; medical research in the fields of pharmacogenomics and pharmacogenetics; providing temporary use of on-line non-downloadable software applications related to medical conditions addressed by medical testing servicesplatform as a service (PAAS) featuring computer software and mobile device applications for accessing information in the field of pain managementmental health and other comorbid conditions; providing genetic testing information for patients and healthcare professionals via an internet website portal; online services relating to medical testing servicesproviding genetic testing and genetic screening information for patients and healthcare professionals via an internet website portal
Classe 44
Medical diagnostic testing services and providing medical information in the form of personalized reports online in the field of genetic testing for medical purposes; providing clinical laboratory testing servicespersonalized medical tests based on the assessmentdevelopment and application of human genomic discoveries in the medical industry; online medical testing servicesgenetic testing and genetic screening; Medical information servicesproviding personalized information online in the field of genetic testing for medical purposes; medical information servicesreporting and providing feedback to patients and healthcare professionals on pharmacogenetic testing service results and relevance to medical and nutritional treatmentspersonal genetic information for pain managementmental health and other comorbid conditions and for understanding individual responses to medicationall the foregoing not including veterinary or plant applications; medical information servicesanalyzing pharmacogenetic testing service results and relevance to medical and nutritional treatmentsthe interaction between personal genetic information and pharmaceuticalsall the foregoing not including veterinary or plant applications; medical information servicespreparation of reports on pharmacogenetic testing service results and relevance to medical and nutritional treatmentsanalyzing individual pharmacogenetics and the interaction between personal genetic information and pharmaceuticalsall the foregoing not including veterinary or plant applications
Publicações
Histórico de despachos e eventos da marca no USPTO.
60 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/10/2023
PUBO
PUBLISHED FOR OPPOSITION
24/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
18/09/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
15/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2023
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
06/06/2023
GPRA
PRIORITY ACTION E-MAILED
06/06/2023
CPRA
PRIORITY ACTION WRITTEN
06/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/02/2023
ALIE
ASSIGNED TO LIE
14/02/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/02/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
06/08/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
06/08/2022
CNSI
SUSPENSION INQUIRY WRITTEN
06/08/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/07/2022
DOCK
ASSIGNED TO EXAMINER
07/03/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/12/2021
GNSL
LETTER OF SUSPENSION E-MAILED
16/12/2021
CNSL
SUSPENSION LETTER WRITTEN
16/12/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/06/2021
GNSL
LETTER OF SUSPENSION E-MAILED
10/06/2021
CNSL
SUSPENSION LETTER WRITTEN
10/06/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/12/2020
GNSL
LETTER OF SUSPENSION E-MAILED
10/12/2020
CNSL
SUSPENSION LETTER WRITTEN
10/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2020
ALIE
ASSIGNED TO LIE
02/12/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/11/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/05/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/05/2020
CNSI
SUSPENSION INQUIRY WRITTEN
01/05/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/11/2019
GNSL
LETTER OF SUSPENSION E-MAILED
01/11/2019
CNSL
SUSPENSION LETTER WRITTEN
01/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/10/2019
ALIE
ASSIGNED TO LIE
23/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/10/2019
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
24/09/2019
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
24/09/2019
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
24/09/2019
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
24/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/08/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/03/2019
GNRT
NON-FINAL ACTION E-MAILED
25/03/2019
CNRT
NON-FINAL ACTION WRITTEN
25/03/2019
DOCK
ASSIGNED TO EXAMINER
25/03/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
21/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2019
NWAP
NEW APPLICATION ENTERED
12/02/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace G ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.